Research progress of EGFR-TKI resistance mechanism and treatment strategy in non-small cell lung cancer
American Journal of Cancer Research · 2026 · 16 (6) · 2562-2576
DOI: 10.62347/nahw4691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Yujia Zhai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The First Affiliated Hospital of Bengbu Medical University Bengbu 233004, Anhui, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, The First Affiliated Hospital of Bengbu Medical University Bengbu 233004, Anhui, China.
- Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical University Bengbu 233004, Anhui, China.
Zitieren
APA
Zhai, Y., Zhou, X., Zhao, W., Fan, W., Li, T., Wang, Y., Zhou, H., & Su, F. (2026). Research progress of EGFR-TKI resistance mechanism and treatment strategy in non-small cell lung cancer. American Journal of Cancer Research, 16(6), 2562-2576. https://doi.org/10.62347/nahw4691
Vancouver
Zhai Y, Zhou X, Zhao W, Fan W, Li T, Wang Y, et al. Research progress of EGFR-TKI resistance mechanism and treatment strategy in non-small cell lung cancer. American Journal of Cancer Research. 2026;16(6):2562-2576. doi:10.62347/nahw4691
BibTeX
@article{Zhai2026,
author = {Zhai, Yujia and Zhou, Xilong and Zhao, Weiming and Fan, Wenjing and Li, Tingting and Wang, Yaqi and Zhou, Huanhuan and Su, Fang},
title = {Research progress of EGFR-TKI resistance mechanism and treatment strategy in non-small cell lung cancer},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {6},
pages = {2562--2576},
doi = {10.62347/nahw4691}
}
EUVIMED